Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
mGluR5 Tumor Mouse Model
Case ID:
TAB-2325
Web Published:
12/6/2022
Glutamate receptor mGluR5 has been reported to function in the brain. There were no prior reports of it being involved in melanoma. The NIH investigators have discovered that when over expressed in transgenic animals, mGluR5 induces melanoma. The establishment of an mGluR5 tumor mouse model will provide a unique opportunity to help elucidate the mechanisms underlying tumor formation, and allow the study of aggressive melanoma in animals and a screen of potential therapeutics. Such an mGluR5 tumor mouse model is established at the National Institutes of Health and is available for licensing.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/mGluR5_Tumor_Mouse_Model
Keywords:
CCXXXX
CXXXXX
MGluR5
Model
Mouse
RXXXXX
tumor
Bookmark this page
Download as PDF
For Information, Contact:
Smita Sharma
NIH Technology Transfer
301-435-7761
smita.sharma@nih.gov